ERBB2 and cancer: The PET tracer, [18F]-AlF-RESCA-MIRC213, showed rapid clearance and specific targeting of HER2-positive tumors in initial human studies (n = 6, breast cancer), making it a promising tool for noninvasive cancer diagnosis [19].